Cash flow Cybin Inc.

Equities

CYBN

CA23256X4075

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:00 2025-12-16 pm EST			5-day change	1st Jan Change
6.660 ^USD	0.00%		+15.83%	-24.49%

Nov. 18	Cybin Inc., Q2 2026 Earnings Call, Nov 13, 2025
Nov. 13	Cybin Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI

5189.gxkh3vgD338b2OleEsv5GpXzWxDA3DnpBMShJWcAZTg.9k1y6oI1nEYov6U_dp2Qd7iSC3qTrnegMPTXcldkNEnhWkSwyzOAMmyTrA

Published financial data: CYBIN INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	864K	-	-	-	-
Total Revenues	864K	-	-	-	-
Cost of Goods Sold, Total	1.18M	-	-	-	-
Gross Profit	-311K	-	-	-	-
Selling General & Admin Expenses, Total	15.87M	28.22M	21.34M	32.59M	45.37M
Stock-Based Compensation (IS)	11.55M	18.03M	4.69M	13.89M	42.87M
R&D Expenses	3.3M	17.59M	25.49M	32.36M	54.91M
Other Operating Expenses, Total	30.72M	63.84M	51.52M	78.84M	143M
Operating Income	-31.04M	-63.84M	-51.52M	-78.84M	-143M
Interest Expense, Total	-10K	-	-	-	-
Interest And Investment Income	60K	241K	603K	619K	8.29M
Net Interest Expenses	50K	241K	603K	619K	8.29M
Currency Exchange Gains (Loss)	-460K	-309K	4.03M	137K	21.75M
Other Non Operating Income (Expenses)	-	-	-	-	-28K
EBT, Excl. Unusual Items	-31.44M	-63.91M	-46.89M	-78.08M	-113M
Gain (Loss) On Sale Of Investments	-63K	-29K	-260K	-	-
Other Unusual Items	-712K	-3.7M	-342K	-	-
EBT, Incl. Unusual Items	-32.22M	-67.63M	-47.49M	-78.08M	-113M
Earnings From Continuing Operations	-32.22M	-67.63M	-47.49M	-78.08M	-113M
Net Income to Company	-32.22M	-67.63M	-47.49M	-78.08M	-113M
Net Income - (IS)	-32.22M	-67.63M	-47.49M	-78.08M	-113M
Net Income to Common Incl Extra Items	-32.22M	-67.63M	-47.49M	-78.08M	-113M
Net Income to Common Excl. Extra Items	-32.22M	-67.63M	-47.49M	-78.08M	-113M
Per Share Items
Net EPS - Basic	-12.24	-15.36	-9.73	-9.41	-5.59
Basic EPS - Continuing Operations	-12.24	-15.36	-9.73	-9.41	-5.59
Basic Weighted Average Shares Outstanding	2.63M	4.4M	4.88M	8.3M	20.22M
Net EPS - Diluted	-12.24	-15.36	-9.88	-9.5	-5.59
Diluted EPS - Continuing Operations	-12.24	-15.36	-9.88	-9.5	-5.59
Diluted Weighted Average Shares Outstanding	2.63M	4.4M	4.88M	8.3M	20.22M
Normalized Basic EPS	-7.47	-9.07	-6	-5.88	-3.5
Normalized Diluted EPS	-7.47	-9.07	-6	-5.88	-3.5
Supplemental Items
EBITDA	-30.99M	-63.67M	-51.28M	-78.58M	-143M
EBITA	-31.04M	-63.84M	-51.5M	-78.8M	-143M
EBIT	-31.04M	-63.84M	-51.52M	-78.84M	-143M
Normalized Net Income	-19.65M	-39.94M	-29.3M	-48.8M	-70.71M
Interest on Long-Term Debt	-	-	-	8K	7K
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	4.94M	3.69M	1.54M	2.79M	6.59M
Selling and Marketing Expenses	4.94M	3.69M	1.54M	2.79M	6.59M
General and Administrative Expenses	10.92M	24.53M	19.81M	29.8M	38.78M
Research And Development Expense From Footnotes	3.3M	17.59M	25.49M	32.36M	54.91M
Stock-Based Comp., Other (Total)	11.58M	18.03M	4.69M	13.89M	42.87M
Total Stock-Based Compensation	11.58M	18.03M	4.69M	13.89M	42.87M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	64.03M	53.64M	16.63M	209M	135M
Total Cash And Short Term Investments	64.03M	53.64M	16.63M	209M	135M
Accounts Receivable, Total	1.33M	-	-	-	-
Other Receivables	-	2.1M	3.05M	4.48M	5.88M
Total Receivables	1.33M	2.1M	3.05M	4.48M	5.88M
Prepaid Expenses	1.13M	1.27M	1.73M	2.89M	22.16M
Other Current Assets, Total	-	1.34M	1.77M	2.18M	2.91M
Total Current Assets	66.48M	58.36M	23.18M	219M	166M
Gross Property Plant And Equipment	611K	713K	903K	1.35M	988K
Accumulated Depreciation	-54K	-222K	-453K	-807K	-847K
Net Property Plant And Equipment	557K	491K	450K	547K	141K
Long-term Investments	-	242K	-	-	-
Goodwill	23.37M	22.89M	24.79M	47.48M	51.49M
Other Intangibles, Total	1.7M	2.08M	5.47M	35.46M	41.02M
Total Assets	92.11M	84.06M	53.9M	302M	259M
Liabilities
Accounts Payable, Total	2.79M	4.23M	5.66M	9.8M	21.42M
Accrued Expenses, Total	-	1.04M	-	-	-
Current Portion of Leases	-	-	-	291K	-
Other Current Liabilities	2.11M	2.65M	-	-	-
Total Current Liabilities	4.9M	7.91M	5.66M	10.1M	21.42M
Other Non Current Liabilities	1.09M	-	-	-	-
Total Liabilities	5.99M	7.91M	5.66M	10.1M	21.42M
Common Stock, Total	101M	141M	158M	444M	464M
Additional Paid In Capital	124K	525K	2.1M	11.75M	44.41M
Retained Earnings	-33.03M	-101M	-148M	-226M	-339M
Comprehensive Income and Other	18.35M	34.84M	36.12M	62.53M	67.79M
Total Common Equity	86.12M	76.16M	48.23M	292M	237M
Total Equity	86.12M	76.16M	48.23M	292M	237M
Total Liabilities And Equity	92.11M	84.06M	53.9M	302M	259M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.91M	4.64M	5.62M	20M	23.03M
ECS Total Common Shares Outstanding	3.89M	4.61M	5.28M	20M	21.61M
Book Value / Share	22.13	16.52	9.13	14.59	10.98
Tangible Book Value	61.05M	51.18M	17.97M	209M	145M
Tangible Book Value Per Share	15.69	11.1	3.4	10.45	6.7
Total Debt	0	0	0	291K	0
Net Debt	-64.03M	-53.64M	-16.63M	-209M	-135M
Account Code - Inventory Valuation	5	5	5	5	6
Machinery, Total	611K	713K	903K	930K	988K
Full Time Employees	38	50	50	50	50

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-32.22M	-67.63M	-47.49M	-78.08M	-113M
Depreciation & Amortization - CF	49K	168K	214K	363K	410K
Amortization of Goodwill and Intangible Assets - (CF)	-	-	19K	37K	39K
Depreciation & Amortization, Total	49K	168K	233K	400K	449K
Amortization of Deferred Charges, Total - (CF)	-	-	18K	24K	26K
(Gain) Loss on Sale of Investments - (CF)	63K	29K	260K	-	-
Asset Writedown & Restructuring Costs	-	-	-	18K	-
Stock-Based Compensation (CF)	11.55M	18.03M	4.69M	13.89M	42.87M
Other Operating Activities, Total	2.79M	3.98M	-3.7M	-129K	-21.71M
Change In Accounts Receivable	-1.48M	-773K	-948K	-1.09M	-1.41M
Change In Inventories	-511K	-	-	-	-
Change In Accounts Payable	1.8M	2.47M	401K	-2.54M	11.61M
Change in Other Net Operating Assets	-1.07M	-1.48M	-890K	-1.39M	-20M
Cash from Operations	-19.03M	-45.21M	-47.43M	-68.91M	-101M
Capital Expenditure	-135K	-105K	-142K	-21K	-1.97M
Cash Acquisitions	-958K	-	-	7.63M	-
Sale (Purchase) of Intangible assets	-96K	-415K	-3.17M	-689K	-
Investment in Marketable and Equity Securities, Total	-	-250K	-	-	-
Cash from Investing	-1.19M	-770K	-3.31M	6.92M	-1.97M
Long-Term Debt Repaid, Total	-	-	-	-149K	-290K
Total Debt Repaid	-	-	-	-149K	-290K
Issuance of Common Stock	76.82M	38.77M	14.51M	271M	21.92M
Other Financing Activities, Total	5.9M	-2.99M	-950K	-16.68M	-1.44M
Cash from Financing	82.72M	35.78M	13.56M	255M	20.2M
Foreign Exchange Rate Adjustments	-28K	-185K	168K	-162K	9.1M
Net Change in Cash	62.48M	-10.38M	-37.01M	192M	-73.97M
Supplemental Items
Levered Free Cash Flow	-5.73M	-21.47M	-34.65M	-34.52M	-57.88M
Unlevered Free Cash Flow	-5.73M	-21.47M	-34.65M	-34.52M	-57.88M
Change In Net Working Capital	-2.27M	-752K	4.08M	-1.15M	9.79M
Net Debt Issued / Repaid	-	-	-	-149K	-290K

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-41.35	-45.29	-46.68	-27.69	-31.92
Return on Total Capital	-44.3	-49.17	-51.77	-28.95	-33.8
Return On Equity %	-73.59	-83.35	-76.36	-45.91	-42.76
Return on Common Equity	-73.59	-83.35	-76.36	-45.91	-42.76
Margin Analysis
Gross Profit Margin %	-36	-	-	-	-
SG&A Margin	1.84K	-	-	-	-
EBITDA Margin %	-3.59K	-	-	-	-
EBITA Margin %	-3.59K	-	-	-	-
EBIT Margin %	-3.59K	-	-	-	-
Income From Continuing Operations Margin %	-3.73K	-	-	-	-
Net Income Margin %	-3.73K	-	-	-	-
Net Avail. For Common Margin %	-3.73K	-	-	-	-
Normalized Net Income Margin	-2.27K	-	-	-	-
Levered Free Cash Flow Margin	-663.67	-	-	-	-
Unlevered Free Cash Flow Margin	-662.95	-	-	-	-
Asset Turnover
Asset Turnover	0.02	-	-	-	-
Receivables Turnover (Average Receivables)	1.23	-	-	-	-
Short Term Liquidity
Current Ratio	13.57	7.38	4.09	21.65	7.75
Quick Ratio	13.34	7.05	3.48	21.14	6.58
Operating Cash Flow to Current Liabilities	-3.88	-5.72	-8.38	-6.83	-4.73
Days Sales Outstanding (Average Receivables)	296.35	-	-	-	-
Average Days Payable Outstanding	474.66	-	-	-	-
Long Term Solvency
Total Debt/Equity	-	-	-	0.1	-
Total Debt / Total Capital	-	-	-	0.1	-
Total Liabilities / Total Assets	6.51	9.41	10.51	3.34	8.28
EBIT / Interest Expense	-3.1K	-	-	-	-
EBITDA / Interest Expense	-3.1K	-	-	-	-
(EBITDA - Capex) / Interest Expense	-3.11K	-	-	-	-
Total Debt / EBITDA	-	-	-	-0	-
Net Debt / EBITDA	2.07	0.84	0.32	2.66	0.95
Total Debt / (EBITDA - Capex)	-	-	-	-0	-
Net Debt / (EBITDA - Capex)	2.06	0.84	0.32	2.66	0.93
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	-	105.48	-19.45	53.21	81.91
EBITA, 1 Yr. Growth %	1.49K	105.7	-19.33	53.01	81.61
EBIT, 1 Yr. Growth %	1.49K	105.7	-19.3	53.03	81.58
Earnings From Cont. Operations, 1 Yr. Growth %	1.56K	109.9	-29.78	64.41	44.9
Net Income, 1 Yr. Growth %	1.56K	109.9	-29.78	64.41	44.9
Normalized Net Income, 1 Yr. Growth %	1.52K	103.23	-26.63	66.52	44.9
Diluted EPS Before Extra, 1 Yr. Growth %	571.16	25.49	-35.69	-3.85	-40.55
Accounts Receivable, 1 Yr. Growth %	1.7K	-	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-	-11.85	-8.35	21.56	-74.22
Total Assets, 1 Yr. Growth %	5.28K	-8.74	-35.88	460.37	-14.37
Tangible Book Value, 1 Yr. Growth %	4.12K	-16.16	-64.88	1.06K	-30.76
Common Equity, 1 Yr. Growth %	5.85K	-11.57	-36.66	505.23	-18.75
Cash From Operations, 1 Yr. Growth %	1.27K	137.59	4.92	45.28	47.01
Capital Expenditures, 1 Yr. Growth %	-	-22.22	35.24	-85.21	176.9
Levered Free Cash Flow, 1 Yr. Growth %	-	274.4	61.41	-0.38	67.66
Unlevered Free Cash Flow, 1 Yr. Growth %	-	274.81	61.41	-0.38	67.66
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	-	28.65	11.09	66.95
EBITA, 2 Yr. CAGR %	-	471.64	28.82	11.1	66.7
EBIT, 2 Yr. CAGR %	-	471.64	28.84	11.13	66.69
Earnings From Cont. Operations, 2 Yr. CAGR %	-	489.83	21.41	7.45	54.35
Net Income, 2 Yr. CAGR %	-	489.83	21.41	7.45	54.35
Normalized Net Income, 2 Yr. CAGR %	-	473.35	22.11	10.53	55.34
Diluted EPS Before Extra, 2 Yr. CAGR %	-	190.21	-10.16	-21.36	-24.74
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-10.12	5.55	-44.02
Total Assets, 2 Yr. CAGR %	-	600.93	-23.51	89.55	119.05
Tangible Book Value, 2 Yr. CAGR %	-	494.52	-45.74	102.07	183.75
Common Equity, 2 Yr. CAGR %	-	625.21	-25.16	95.79	121.76
Cash From Operations, 2 Yr. CAGR %	-	471.36	57.89	23.46	46.14
Capital Expenditures, 2 Yr. CAGR %	-	-	2.56	-55.28	272.09
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	145.83	26.81	29.24
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	145.97	26.81	29.24
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	-	-	36.37	30.94
EBITA, 3 Yr. CAGR %	-	-	197.61	36.42	30.88
EBIT, 3 Yr. CAGR %	-	-	197.65	36.44	30.89
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	190.16	34.32	18.71
Net Income, 3 Yr. CAGR %	-	-	190.16	34.32	18.71
Normalized Net Income, 3 Yr. CAGR %	-	-	188.93	35.41	20.97
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	75.62	-8.11	-28.58
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	-0.6	-34.02
Total Assets, 3 Yr. CAGR %	-	-	215.82	48.56	45.44
Tangible Book Value, 3 Yr. CAGR %	-	-	131.53	50.71	41.4
Common Equity, 3 Yr. CAGR %	-	-	221.76	50.22	46.04
Cash From Operations, 3 Yr. CAGR %	-	-	224.76	53.57	30.86
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-46.22	165.54
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	81.92	39.18
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	81.99	39.18
Compound Annual Growth Rate Over Five Years
EBITA, 5 Yr. CAGR %	-	-	-	-	136.03
EBIT, 5 Yr. CAGR %	-	-	-	-	136.04
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	125.41
Net Income, 5 Yr. CAGR %	-	-	-	-	125.41
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	125.41
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	25.13
Total Assets, 5 Yr. CAGR %	-	-	-	-	172.82
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	151.15
Common Equity, 5 Yr. CAGR %	-	-	-	-	177.25
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	135.96